Guard Therapeutics International AB - Asset Resilience Ratio

Latest as of September 2025: 98.42%

Guard Therapeutics International AB (GUARD) has an Asset Resilience Ratio of 98.42% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See GUARD current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

Skr69.76 Million

≈ $7.51 Million USD Cash + Short-term Investments

Total Assets

Skr70.88 Million

≈ $7.63 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2023)

This chart shows how Guard Therapeutics International AB's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Guard Therapeutics International AB assets under control.

Liquid Assets Composition Over Time

This chart breaks down Guard Therapeutics International AB's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read Guard Therapeutics International AB debt and liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr69.76 Million	98.42%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr69.76 Million	98.42%

Asset Resilience Insights

Very High Liquidity: Guard Therapeutics International AB maintains exceptional liquid asset reserves at 98.42% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Guard Therapeutics International AB Industry Peers by Asset Resilience Ratio

Compare Guard Therapeutics International AB's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Rapport Therapeutics, Inc. Common Stock NASDAQ:RAPP	Biotechnology	81.15%
Galecto Inc NASDAQ:GLTO	Biotechnology	0.00%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Guangzhou Boji Medical and Biotechnological Co Ltd SHE:300404	Biotechnology	13.78%

Annual Asset Resilience Ratio for Guard Therapeutics International AB (2016–2023)

The table below shows the annual Asset Resilience Ratio data for Guard Therapeutics International AB.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2023-12-31	98.26%	Skr83.74 Million ≈ $9.01 Million	Skr85.23 Million ≈ $9.17 Million	-0.96pp
2022-12-31	99.21%	Skr201.01 Million ≈ $21.63 Million	Skr202.60 Million ≈ $21.80 Million	+0.17pp
2021-12-31	99.04%	Skr188.60 Million ≈ $20.30 Million	Skr190.44 Million ≈ $20.49 Million	+0.33pp
2020-12-31	98.71%	Skr90.04 Million ≈ $9.69 Million	Skr91.22 Million ≈ $9.82 Million	+14.21pp
2019-12-31	84.50%	Skr53.84 Million ≈ $5.79 Million	Skr63.71 Million ≈ $6.86 Million	+33.32pp
2018-12-31	51.18%	Skr13.96 Million ≈ $1.50 Million	Skr27.28 Million ≈ $2.94 Million	+33.74pp
2017-12-31	17.44%	Skr7.61 Million ≈ $819.17K	Skr43.65 Million ≈ $4.70 Million	+0.94pp
2016-12-31	16.50%	Skr7.01 Million ≈ $754.28K	Skr42.47 Million ≈ $4.57 Million	--

pp = percentage points

About Guard Therapeutics International AB

ST:GUARD Sweden Biotechnology

Market Cap

$3.19 Million

Skr29.61 Million SEK

Market Cap Rank

#29412 Global

#665 in Sweden

Share Price

Skr1.47

Change (1 day)

+1.24%

52-Week Range

Skr0.95 - Skr25.90

All Time High

Skr3260.75